Prostate Cancer

News and new technology innovations concerning how imaging technology can help diagnose and treat prostate cancer can be found on this channel.

Pluvicto
News | Prostate Cancer
FDA Approves Novartis' Pluvicto for Prostate Cancer Patients

March 28, 2025 — Novartis has announced that the US Food and Drug Administration (FDA) approved Pluvicto (lutetium Lu ...

Time March 31, 2025
arrow
News | Prostate Cancer
UCSF Performs First Application of RSI-MRI with Robotic HiFU for Prostate Cancer

Feb. 12, 2025 — Cortechs.ai, a supplier of novel imaging solutions for prostate cancer care, and EDAP TMS SA, a provider ...

Time February 13, 2025
arrow
News | Prostate Cancer
Ibex Medical Analytics Earns First FDA Clearance for Prostate Detect

Feb. 10, 2025 —Ibex Medical Analytics recently announced it has received U.S. Food and Drug Administration (FDA) 510(k) ...

Time February 10, 2025
arrow
News | Prostate Cancer
Study: HIFU Comparable to Radical Prostatectomy, Less Side Effects

Dec. 4, 2024 - EDAP TMS SA, a leader in robotic energy-based therapies, recently announced the publication of the full ...

Time December 18, 2024
arrow
News | Prostate Cancer
New Study Confirms AI’s Power in Detecting Prostate Cancer

Sept. 4, 2024 — A recently published study in BJUI Compass confirms that Unfold AI, an FDA-cleared artificial ...

Time September 04, 2024
arrow
POSLUMA (flotufolastat F 18) PET/CT image showing uptake in the prostate gland, consistent with primary prostate cancer.
News | Prostate Cancer
Blue Earth Diagnostics, a Bracco Company, Announces Results Evaluating Diagnostic Performance of POSLUMA (Flotufolastat F 18) and Clinical Trial Enrollment in African American Men with Prostate Cancer

July 30, 2024 — Blue Earth Diagnostics, a Bracco company and recognized leader in the development and commercialization ...

Time July 30, 2024
arrow
Telix Pharmaceuticals Limited announced that the United States (U.S.) Food and Drug Administration (FDA) has accepted the filing of its New Drug Application (NDA) for TLX007-CDx
News | Radiopharmaceuticals and Tracers
FDA Accepts Telix NDA for New Prostate Cancer Imaging Agent

July 24, 2024 — Telix Pharmaceuticals Limited announced that the United States (U.S.) Food and Drug Administration (FDA) ...

Time July 24, 2024
arrow
Guidance from preoperative magnetic resonance imaging (MRI) helps clinicians deliver more precise high dose-rate (HDR) prostate brachytherapy treatments
News | Prostate Cancer
GE HealthCare’s MIM Software Introduces MIM Symphony HDR Prostate for MR Image Guidance During Procedures

July 11, 2024 — GE HealthCare’s MIM Software, a global provider of medical imaging analysis and artificial intelligence ...

Time July 11, 2024
arrow
Deal further strengthens Lantheus’ prostate cancer portfolio and expands pipeline to include breast cancer
News | Prostate Cancer
Lantheus Acquires Global Rights to Life Molecular Imaging’s Novel Therapeutic and Diagnostic Pair Targeting GRPR for Prostate and Breast Cancers

July 5, 2024 — Lantheus Holdings, Inc., a leading radiopharmaceutical-focused company committed to enabling clinicians ...

Time July 05, 2024
arrow
The deployment of DL segmentation methods in 18F-fluciclovine PET/CT imaging represents an intriguing research direction for precision medicine in salvage prostate cancer care
News | Prostate Cancer
Deep Learning-assisted Lesion Segmentation in PET/CT Imaging: A Feasibility Study for Salvage Radiation Therapy in Prostate Cancer

July 2, 2024 — A new editorial paper was published in Oncoscience (Volume 11) on May 20, 2024, entitled, “Deep learning ...

Time July 02, 2024
arrow
Avenda Health’s study, published in The Journal of Urology, solidifies the power of AI in oncology as a viable and accurate diagnostic tool
News | Artificial Intelligence
New Study Proves AI Enhances Physicians’ Ability to Identify Extent of Prostate Cancer with 84 Percent Accuracy

June 17, 2024 — Avenda Health, an AI healthcare company creating the future of personalized prostate cancer care ...

Time June 17, 2024
arrow
Latest innovations in clinical cancer research discussed at American Society of Clinical Oncology (ASCO) Annual Meeting
News | Radiopharmaceuticals and Tracers
Shine Technologies Partners with Blue Earth Therapeutics for First Supply of Ilumira from Its New Facility

June 7, 2024 — Shine Technologies, LLC, a pioneer in next-generation fusion-based technology, today announced a new ...

Time June 07, 2024
arrow
A new UCLA study found Unfold AI’s precise prediction of prostate margins significantly impacts the success of focal therapy treatments
News | Prostate Cancer
New Study Demonstrates Avenda Health’s Unfold AI to Better Predict Focal Therapy Success by 77% Percent as Compared to Standard Methods

May 13, 2024 — Avenda Health, an AI healthcare company creating the future of personalized prostate cancer care, unveils ...

Time May 13, 2024
arrow
Extending beyond brain tumors, empowering patients with treatment options in prostate cancer and other malignancies
News | Prostate Cancer
GT Medical Technologies, Inc and Theragenics Corporation Forge Distribution Partnership for Cesium-131

May 2, 2024 — GT Medical Technologies, Inc. (GT MedTech), a medical device company with the mission of improving the ...

Time May 02, 2024
arrow
new 3-part video series on advancements in diagnostic radiology with Robert L. Bard, MD, PC, DABR, FASLMS
Feature | Radiation Oncology | By Melinda Taschetta-Millane
Advancements in Diagnostic Radiology Video Series with Robert L. Bard, MD, PC, DABR, FASLMS

In a new 3-part video series on advancements in diagnostic radiology with Robert L. Bard, MD, PC, DABR, FASLMS ...

Time April 10, 2024
arrow
Minimally invasive procedure provides disease control without devastating side effects
News | Prostate Cancer
New Treatment Option for Prostate Cancer Shows Successful Outcomes

March 27, 2024 — A minimally invasive treatment using MRI and transurethral ultrasound instead of surgery or radiation ...

Time March 27, 2024
arrow
For the first time in a commercial setting, physicians are able to see the extent of disease and provide more personalized and precise treatments for prostate cancer patients using AI
News | Artificial Intelligence
Avenda Health Announces First Commercial Use of Unfold AI on Prostate Cancer Patients in the US

March 21, 2024 — Avenda Health, an AI healthcare company creating the future of personalized prostate cancer care ...

Time March 21, 2024
arrow
Videos | Radiation Oncology
VIDEO: Advancements and New Technology in Diagnostic Radiology to Help in the Fight Against Cancer

In the conclusion of this 3-part video series on recent advancements in diagnostic radiology, current editorial advisory ...

Time March 19, 2024
arrow
DeepHealth is a global leader in providing AI-powered radiology and health informatics for real-world clinical settings and large-scale screening programs
News | Artificial Intelligence
DeepHealth to Present Latest Results from AI-powered Screening and Diagnostic Programs at the European Congress of Radiology 2024

February 26, 2024 — DeepHealth, Inc., one of the leading providers in healthcare radiology informatics, has today ...

Time February 26, 2024
arrow
First reported clinical results from independent clinical experience by University of Augsburg demonstrated encouraging preliminary data for 177Lu-rhPSMA-10.1
News | Radiopharmaceuticals and Tracers
Blue Earth Therapeutics Announces Publication of Results from Independent Clinical Experience with 177Lu-rhPSMA-10.1 in Treatment of Metastatic Castrate Resistant Prostate Cancer

February 21, 2024 — Blue Earth Therapeutics, a Bracco company and emerging leader in the development of innovative next ...

Time February 21, 2024
arrow
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now